Ranked America's #1 Heart Center U.S. News & World Report
Part of The Ohio 3rd Frontier Project
The Cleveland Clinic Foundation, together
with its institutional partners, Case
Western Reserve University and the University
of Cincinnati, and its commercial partners has received a grant
from the state of Ohio to establish the Atrial Fibrillation Innovation
Center (AFIC), a Wright Center of Innovation. Launched in the summer
of 2005, AFIC falls under Ohio's Third Frontier human genetics and
biomedical engineering initiative, and is spearheading the charge
to address the great suffering imposed by atrial fibrillation (AF),
while catalyzing an emerging Ohio AF medical device industry. AFIC
represents the largest single government grant in the world to support
Atrial Fibrillation research.
The AFIC's uniquely qualified team — the
nation's largest and most innovative clinical programs, fundamental
researchers and an unrivaled commercialization group —
are jointly implementing an exceptionally collaborative five-prong
research program to ensure that new AF therapies quickly come to
market for the benefit of AF sufferers. State of the art cardiac
mapping and experimental labs will be utilized by the group to:
Develop new surgical treatment technologies.
Improve catheter-enabled treatment techniques
and instrumentation.
Conduct basic science and translational studies
into biochemical cellular and genetic causes for, and treatments
of, AF.
Develop next generation AF treatment strategies.
Specify novel patient assessments to better document
therapy outcomes and AF mechanisms.
A principal goal of Ohio's Third Frontier Project is to develop
"clusters of excellence that sustain [Ohio's] global competitive
advantage in company and product formation, job creation
and economic growth." AFIC is dedicated to ensuring its
current programs and new projects contribute to the state's
economic development goals, making an impact in each of
these important areas. Read
more...
Through its successes
in ground-breaking research and industrial partnerships,
AFIC will come to be recognized as a world leader in
the development of diagnostic and therapeutic solutions
for Atrial Fibrillation. In the process, AFIC hopes
to contribute to lo cal economic development in the
Northeast Ohio region, by attracting AF companies to
the region, by creating new AF companies around AFIC
research results, and by expanding our research and
development base.
Read more...
With Atrial Fibrillation
affecting more Ohioans each year, research, therapies
and technologies are needed more than ever. Learn more
about AFIC in this presentation.
Read
more...